Authors:
DAHLOF C
HOGENHUIS L
OLESEN J
PETIT H
RIBBAT J
SCHOENEN J
BOSWELL D
FUSEAU E
HASSANI H
WINTER P
Citation: C. Dahlof et al., EARLY CLINICAL-EXPERIENCE WITH SUBCUTANEOUS NARATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A DOSE-RANGING STUDY, European journal of neurology, 5(5), 1998, pp. 469-477
Authors:
BOMHOF MAM
HEYWOOD J
PRADALIER A
ENAHORO H
WINTER P
HASSANI H
Citation: Mam. Bomhof et al., TOLERABILITY AND EFFICACY OF NARATRIPTAN TABLETS WITH LONG-TERM TREATMENT (6 MONTHS), Cephalalgia, 18(1), 1998, pp. 33-37
Citation: C. Dahlof et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON OF ORAL NARATRIPTAN AND ORAL SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE, Neurology, 48(3), 1997, pp. 8003-8003
Citation: Jg. Maconochie et al., DOSE-RELATED PROTECTION AGAINST HISTAMINE-INDUCED BRONCHOCONSTRICTIONBY INHALED SALMETEROL, International journal of clinical pharmacology and therapeutics, 32(7), 1994, pp. 329-334